﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Longs Drugs news stories on Newser</title><description>Read more Longs Drugs stories on Newser</description><link>http://www.newser.com/taggrid/34649/longs-drugs.html</link><image><url>http://img1-cdn.newser.com/images/newser-black250x40.gif</url><title>Longs Drugs news stories on Newser</title><link>http://www.newser.com/</link></image><copyright>2012 - Newser</copyright><language>en-us</language><generator>Newser Feed Generator</generator><pubDate>Fri, 25 May 2012 20:24:10 CDT</pubDate><item><guid isPermaLink="true">http://www.newser.com/story/37683/longs-picks-cvs-despite-walgreens-higher-bid.html</guid><title>Longs Picks CVS Despite Walgreen's Higher Bid</title><dc:creator>Ambreen Ali</dc:creator><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=136763&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401003514' border='0' /&gt;Longs Drugs today declined Walgreen’s premium buyout offer, opting for CVS’ in the pharmacy-market tussle, the AP reports. Longs’ largest shareholder calls the choice "totally unfair," but the board maintains that a Walgreen deal could get bogged down in antitrust review. Longs' stock dipped on the news, indicating that investors...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=136763&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401003514" type="image/jpg" medium="image"><media:description type="plain">Longs Drugs rejected a Walgreen buyout offer with a $3.50 premium per share over CVS.</media:description></media:content><link>http://www.newser.com/story/37683/longs-picks-cvs-despite-walgreens-higher-bid.html</link><pubDate>Wed, 17 Sep 2008 14:41:00 CDT</pubDate></item></channel></rss>
